MetLife Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.64M | Buy |
|
|||||
|
2025
Q2 | $2.53M | Buy |
|
|||||
|
2025
Q1 | $1.97M | Sell |
|
|||||
|
2024
Q4 | $1.72M | Sell |
|
|||||
|
2024
Q3 | $2.01M | Sell |
|
|||||
|
2024
Q2 | $1.81M | Buy |
|
|||||
|
2024
Q1 | $987K | Buy |
|
|||||
|
2023
Q4 | $1.24M | Sell |
|
|||||
|
2023
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q2 | $1.25M | Sell |
|
|||||
|
2023
Q1 | $1.49M | Buy |
|
|||||
|
2022
Q4 | $1.77M | Sell |
|
|||||
|
2022
Q3 | $1.5M | Buy |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $1.27M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $12.1K | Buy |
|
|||||
|
2018
Q4 | $8.89K | Sell |
|
|||||
|
2018
Q3 | $10.8K | Buy |
|